The value of timely treatment with anti-amyloid therapy for Alzheimer's disease.

Jack M Chapel; Bryan Tysinger; Hossein Pourmand; Dana Goldman; Paul Aisen; Alzheimer's Disease Neuroimaging Initiative

doi:10.1002/alz.71819

SCHEDA SCIENTIFICA2026Altra ricerca

The value of timely treatment with anti-amyloid therapy for Alzheimer's disease.

Jack M Chapel, Bryan Tysinger, Hossein Pourmand, Dana Goldman, Paul Aisen, Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

Psicologia clinica Psicoterapia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansAlzheimer DiseaseDisease ProgressionAgedFemaleTreatment DelayQuality of LifeUnited StatesMaleHealth Care CostsCost-Benefit AnalysisAlzheimer's diseaseanti‐amyloid therapycare pathwaydonanemabmicrosimulationsocial value

Come citare questo studio

Jack M Chapel, Bryan Tysinger, Hossein Pourmand, Dana Goldman, Paul Aisen, Alzheimer's Disease Neuroimaging Initiative. (2026). The value of timely treatment with anti-amyloid therapy for Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. DOI: 10.1002/alz.71819

Consulta la pubblicazione originale ↗